KEYS · Keysight Technologies, Inc.

Current Thesis

Keysight Technologies' AI-testing order surge supports an earnings-delivery recovery, conditional on meeting fiscal Q4 revenue guidance and regaining the market's prior high before losing the post-results reference close. The measurable case is Q4 revenue within the company's $1.930B–$1.950B range, issued on 2026-08-18, together with a weekly close above the $373.34 trailing-year high recorded in the 2026-09-18 price snapshot. A weekly close below $319.45, the market's 2026-08-19 post-results close, invalidates this recovery thesis.

The calendar has advanced since the 2026-09-06 assessment. Keysight's event archive lists both the 2026-09-11 Goldman Sachs conference and the 2026-09-15 Truist Technology Symposium; both dates have passed. Their appearance on the calendar establishes scheduled management access, not a subsequent improvement in orders or component availability. Keysight event archive.

The narrative is maturing — an inference from the eight broker target increases clustered on 2026-08-19, the elapsed September conference dates and the 2026-09-18 close remaining below the trailing-year high. The supplied adjusted-price series records a $335.00 close, 10.3% below that high, and a three-month decline of 10.3%. These observations support an established story awaiting delivery; they do not establish exhausted demand or crowded ownership.

Bullish and bearish views on Keysight Technologies, Inc.

The model's bull view on Keysight Technologies, Inc. (KEYS), in brief: Orders support the delivery case. Keysight's 2026-08-18 results reported fiscal Q3 orders of $2.091B, up 56% year over year, and revenue of $1.846B, up 36%. The order figure supports the demand leg; conversion remains subject to the Q4 revenue test. Guidance supplies a… The bear view: Analyst enthusiasm lacked immediate confirmation. Both cases follow in full.

Bull Case

• Orders support the delivery case. Keysight's 2026-08-18 results reported fiscal Q3 orders of $2.091B, up 56% year over year, and revenue of $1.846B, up 36%. The order figure supports the demand leg; conversion remains subject to the Q4 revenue test.
• Guidance supplies a measurable hurdle. On 2026-08-18, Keysight guided fiscal Q4 revenue to $1.930B–$1.950B and adjusted earnings per share to $3.34–$3.40. Revenue below the lower boundary would reject the earnings-delivery premise. Fiscal Q3 results.
• Cash generation accompanies reported growth. Keysight's 2026-08-18 release reported fiscal Q3 operating cash flow of $437M and free cash flow of $403M. These are measured quarterly outcomes, not evidence that subsequent orders have already converted. Fiscal Q3 results.

Bear Case

• Analyst enthusiasm lacked immediate confirmation. Benzinga's 2026-08-19 reports recorded eight target increases, including UBS and Susquehanna at $440 and Truist at $400 with a Hold rating. The market closed that day at $319.45, down 6.3%, according to the contemporaneous coverage. This documents clustered commentary and a negative price response, not investor ownership concentration.
• Contract disclosures leave conversion uncertain. The fiscal Q3 Form 10-Q filed on 2026-09-02 disclosed approximately $616M of remaining performance obligations across 2026–2028. That disclosure does not establish that the entire $2.091B fiscal Q3 order intake is contracted revenue; the two measures cannot be treated as interchangeable.
• Inventory does not establish availability. The same filing reported inventory of $1,047M at 2026-07-31 versus $1,050M at 2025-10-31. Those totals neither quantify the incoming-parts constraint described on the 2026-08-18 call nor prove that the required component mix is available.

Setup & Price Structure

The 2026-09-18 adjusted daily close of $335.00 stands above the market's $319.45 post-results close on 2026-08-19, but below the $373.34 trailing-year high in the September snapshot. The 14-day relative strength index was 58.5 on 2026-09-18. No current moving-average measurement or volume series is supplied, so neither distance above a rising average nor expanding participation can be established.

The recovery condition uses $319.45 because it is an observable post-results reference close; it is not presented as a repeatedly tested support shelf. The supplied 2026-08-19 coverage cluster establishes analyst attention. Current retail-flow, short-interest, insider-transaction and issuance measurements are missing, leaving ownership crowding unmeasured.

Catalyst Calendar (next 30 days)

• 2026-09-20 through 2026-10-20: No company-dated investor event is listed on Keysight's upcoming-events page as checked on 2026-09-20. This is a calendar observation, not a prediction that no announcement will occur. Keysight upcoming events.
• 2026-10-31: Keysight's fiscal Q4 and fiscal year end. This later accounting date closes the revenue period underlying the $1.930B–$1.950B guidance issued on 2026-08-18; it is not the earnings-release date. The results-publication date remains unconfirmed in the company's calendar as checked on 2026-09-20.

What Would Change Our Mind

Loss of the post-results recovery would break the price case: a weekly close below $319.45 would put the shares below their 2026-08-19 reference close. Fiscal Q4 revenue below $1.930B, the low end of the company's 2026-08-18 guidance, would separately break the delivery premise even if price remained above that threshold.

Confirmation requires both operating delivery and price acceptance: fiscal Q4 revenue within the published range and a weekly close above the $373.34 trailing-year high recorded on 2026-09-18, before the invalidation condition occurs. Conference appearances alone cannot satisfy either test.

Correlation Notes

This remains a single-name setup rather than a demonstrated group move. Keysight's 2026-08-18 results reported Communications Solutions revenue of $1,345M, up 43% year over year, including commercial-communications growth of 56%; that provides an operating link to communications infrastructure demand. It does not measure stock-price correlation with networking or optical-component companies. Fiscal Q3 results.

No matched peer-return series accompanies the 2026-09-18 price snapshot. The evidence is insufficient to claim that a sector advance confirms Keysight's recovery or that peer exposure provides diversification.